• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pyrimidine-based inhibitors of CaMKIIdelta.

作者信息

Mavunkel Babu, Xu Yong-Jin, Goyal Bindu, Lim Don, Lu Qing, Chen Zheng, Wang Dan-Xiong, Higaki Jeffrey, Chakraborty Indrani, Liclican Albert, Sideris Steve, Laney Maureen, Delling Ulrike, Catalano Rosanne, Higgins Linda S, Wang Hui, Wang Jing, Feng Ying, Dugar Sundeep, Levy Daniel E

机构信息

Scios, Inc., 6500 Paseo Padre Parkway, Fremont, CA 94555, USA.

出版信息

Bioorg Med Chem Lett. 2008 Apr 1;18(7):2404-8. doi: 10.1016/j.bmcl.2008.02.056. Epub 2008 Mar 4.

DOI:10.1016/j.bmcl.2008.02.056
PMID:18334293
Abstract

Non-ATP competitive pyrimidine-based inhibitors of CaMKIIdelta were identified. Computational studies were enlisted to predict the probable mode of binding. The results of the computational studies led to the design of ATP competitive inhibitors with optimized hinge interactions. Inhibitors of this class possessed improved enzyme and cellular activity compared to early leads.

摘要

相似文献

1
Pyrimidine-based inhibitors of CaMKIIdelta.
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2404-8. doi: 10.1016/j.bmcl.2008.02.056. Epub 2008 Mar 4.
2
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2390-4. doi: 10.1016/j.bmcl.2008.02.059. Epub 2008 Mar 4.
3
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2399-403. doi: 10.1016/j.bmcl.2008.02.057. Epub 2008 Mar 4.
4
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.芳基吲哚马来酰亚胺作为钙/钙调蛋白依赖性蛋白激酶IIdelta的抑制剂。第2部分:胺连接链的构效关系。
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2395-8. doi: 10.1016/j.bmcl.2008.02.058. Epub 2008 Mar 4.
5
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.CDK4抑制的结构决定因素及选择性ATP竞争性抑制剂的设计
Chem Biol. 2004 Apr;11(4):525-34. doi: 10.1016/j.chembiol.2004.03.022.
6
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.作为IKK抑制剂的2-苯甲酰胺基嘧啶的设计与制备
Bioorg Med Chem Lett. 2006 Jan 1;16(1):108-12. doi: 10.1016/j.bmcl.2005.09.035. Epub 2005 Oct 19.
7
The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck).基于新型1,2 - 二氢 - 嘧啶并[4,5 - c]哒嗪的淋巴细胞特异性激酶(Lck)抑制剂的开发。
Bioorg Med Chem Lett. 2006 Aug 15;16(16):4257-61. doi: 10.1016/j.bmcl.2006.05.072. Epub 2006 Jun 6.
8
Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.强效且选择性的氮杂吲哚基Rho激酶(ROCK)抑制剂的设计与合成。
ChemMedChem. 2008 Dec;3(12):1893-904. doi: 10.1002/cmdc.200800211.
9
Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.新型2-(N'-亚苄基肼基)-4-三氟甲基嘧啶的汇聚合成及克沙毒蛋白酶抑制活性
Bioorg Med Chem. 2008 Dec 15;16(24):10236-43. doi: 10.1016/j.bmc.2008.10.052. Epub 2008 Oct 25.
10
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.蛋白激酶抑制的新范式:在不直接靶向ATP结合的情况下阻断磷酸化。
Drug Discov Today. 2007 Aug;12(15-16):622-33. doi: 10.1016/j.drudis.2007.06.008. Epub 2007 Aug 2.

引用本文的文献

1
Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy.钙调蛋白激酶 II 在糖尿病诱导的血管损伤中的作用及其与抗糖尿病治疗的相互作用。
Rev Endocr Metab Disord. 2024 Apr;25(2):369-382. doi: 10.1007/s11154-023-09855-9. Epub 2023 Dec 8.
2
Pharmacological profiling of a berbamine derivative for lymphoma treatment.贝母素甲衍生物治疗淋巴瘤的药理学特征分析。
Blood Adv. 2024 Jan 23;8(2):309-323. doi: 10.1182/bloodadvances.2023010873.
3
Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp.
作为 P-糖蛋白介导的多药耐药性的逆转剂,喹啉酮-嘧啶类混合物的构效关系和结合模式。
Sci Rep. 2021 Aug 19;11(1):16856. doi: 10.1038/s41598-021-96226-6.
4
Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.心脏中钙调蛋白激酶II治疗靶点的挑战与机遇
Front Pharmacol. 2020 Feb 5;11:35. doi: 10.3389/fphar.2020.00035. eCollection 2020.
5
Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors.设计新型喹啉-2(1H)-酮-嘧啶类化合物作为鞘氨醇激酶抑制剂。
Bioorg Chem. 2020 Jan;94:103414. doi: 10.1016/j.bioorg.2019.103414. Epub 2019 Nov 13.
6
Using Machine Learning To Predict Suitable Conditions for Organic Reactions.使用机器学习预测有机反应的合适条件。
ACS Cent Sci. 2018 Nov 28;4(11):1465-1476. doi: 10.1021/acscentsci.8b00357. Epub 2018 Nov 16.
7
Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor.新型嘧啶基 CaMKII 抑制剂改善心肌细胞功能。
J Mol Cell Cardiol. 2018 Feb;115:73-81. doi: 10.1016/j.yjmcc.2017.12.015. Epub 2017 Dec 30.
8
Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment.用于心血管疾病治疗的激酶酶及抑制剂的研究进展
Future Sci OA. 2017 Aug 8;3(4):FSO204. doi: 10.4155/fsoa-2017-0010. eCollection 2017 Nov.
9
CaMKII inhibitors: from research tools to therapeutic agents.钙调蛋白激酶II抑制剂:从研究工具到治疗药物。
Front Pharmacol. 2014 Feb 20;5:21. doi: 10.3389/fphar.2014.00021. eCollection 2014.
10
One-pot Double Suzuki Couplings of Dichloropyrimidines.二氯嘧啶的一锅法双铃木偶联反应
Synthesis (Stuttg). 2010 Aug 1;2010(16):2721-2724. doi: 10.1055/s-0030-1258150.